Again acquires Geno to advance biomanufacturing at scale with AI design
Denmark's Again acquires Genomatica to marry AI-designed biomolecules with modular bioreactors—a vertical integration play in the emerging biotech-AI stack.
Why it matters
An acquisition combining AI molecular design with industrial-scale biomanufacturing signals how frontier AI capabilities are being embedded into non-tech verticals. This matters to practitioners building or investing in biotech stacks and to enthusiasts tracking AI's expansion beyond software.
The key facts
10 to knowAgain (Denmark, LuaBio ApS) acquires Genomatica
Deal combines Geno's AI discovery/design platform for biomolecules with Again's modular bioreactors
Again's model: co-locates bioreactors with industrial CO2 emitters, feeds waste gas directly into fermentation
Vertical integration of AI design + manufacturing at scale
Published Aug 12, 2026
LuaBio ApS (Again) acquires Genomatica Inc.
Combines biomanufacturing platform with AI biomolecule discovery and design
Again operates modular bioreactors with engineered microbes
Integration of waste CO2 capture into fermentation
Announced August 12, 2026
Go to the source
SiliconAnglesiliconangle.com
Publisher excerpt: Denmark-based LuaBio ApS, operating as Again, today announced the acquisition of Genomatica Inc. to combine the company’s cutting-edge biomanufacturing capabilities with Geno’s artificial intelligence discovery and design platform for biomolecules. Again co-locates modular bioreactors that use…